Bridgebio Pharma, Inc. · NASDAQ:BBIO

Apuli Maricel had 4,714 Bridgebio Pharma, Inc. shares withheld for tax (Form 4)

Traded May 16, 2026 · Filed May 19, 2026

On May 16, 2026, Apuli Maricel (Chief Accounting Officer) had 4,714 Bridgebio Pharma, Inc. shares withheld for tax at US$66.13 for US$312K, leaving 129,401 shares. Filed May 19, 2026 (Form 4).

Withheld for tax
4,714 shares
Price
US$66.13
Value
US$312K
Holding after
129,401 shares
Trading plan
No
Role
Chief Accounting Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 16, 2026Common StockShares withheld for tax4,714US$66.13129,401Direct

Source

View original at SEC

Related